<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-26-01093-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">molecules-26-01093-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Potential of EOs as antifungal agents in human skin disease.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No.</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Techniques</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Skin Infections/
     <break/>Fungi Species
    </th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Essential Oils</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Methods</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Findings</th>
    <th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Conclusion</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B58-molecules-26-01093" ref-type="bibr">58</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections (
     <italic>C. albicans</italic>, 
     <italic>C. parapsilosis</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ten EOs: oregano, thyme, clove, arborvitae, cassia, lemongrass, melaleuca, eucalyptus, lavender, and clary sage</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO compositions were determined using gas chromatography-mass spectrometry (GC/MS).</p>
      </list-item>
      <list-item>
       <p>The genotoxic effects on healthy human keratinocytes HaCaT of the tested EOs were evaluated using the comet assay</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Oregano (76.73% carvacrol), thyme (53.26% thymol), cassia (77.83% eugenol), lemongrass (45.72% geranial) and arborvitae (55.96% methyl thujate) showed very strong antifungal activity against all tested strains.</p>
      </list-item>
      <list-item>
       <p>The results revealed that none of the EO induced significant DNA damage in vitro after 24 h.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>These results showed that these ten EOs may be effective in preventing the growth of the drug-resistant microorganisms which are responsible for wound infections. This EO could be used as a potential source of safe and potent natural antimicrobial and antioxidant agents in the pharmaceutical and food industries.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B59-molecules-26-01093" ref-type="bibr">59</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dermatophytosis by dermatophytes (
     <italic>Trichophyton rubrum</italic> PTCC (Persian Type Culture Collection)5143, 
     <italic>T. mentagrophytes</italic> PTCC5054, 
     <italic>Microsporum</italic> canis PTCC5069, 
     <italic>M. gypseum</italic> PTCC 5070, 
     <italic>T. schoenleinii</italic> PTCC5221, 
     <italic>T. verrucosum</italic> var. album PTCC 5056)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Artemisia sieberi</italic> oils 
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Analysis of five 
        <italic>A. sieberi</italic> oils (different harvesting times and distinctive collecting locations) by gas chromatography-flame ionization detector (GC-FID) and GC-MS.
       </p>
      </list-item>
      <list-item>
       <p>Antifungal activities of 
        <italic>A. sieberi</italic> oils were evaluated against different dermatophytes.
       </p>
      </list-item>
      <list-item>
       <p>The oils were examined for antidermatophyte activity by the poisoned food technique.</p>
      </list-item>
      <list-item>
       <p>MIC and MFC were determined by broth microdilution assay.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The results showed that the harvesting time and collecting location affect the chemical composition and oil yields.</p>
      </list-item>
      <list-item>
       <p>The main components were santolina alcohol, camphor, α-thujone and β-thujone. No significant difference between the desirable antidermatophyte activities of 
        <italic>A</italic>. 
        <italic>sieberi</italic> oils with different chemical compositions.
       </p>
      </list-item>
      <list-item>
       <p>
        <italic>M</italic>. 
        <italic>gypseum</italic>, 
        <italic>T</italic>. 
        <italic>rubrum</italic> and 
        <italic>M</italic>. 
        <italic>canis</italic> had more sensitivity than others to 
        <italic>A</italic>. 
        <italic>sieberi</italic> oils.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>A</italic>. 
        <italic>sieberi</italic> can be used as topical antifungal agent for the treatment of skin dermatophyte infections.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">3.</td>
    <td rowspan="12" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Conventional technology</td>
    <td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[
     <xref rid="B60-molecules-26-01093" ref-type="bibr">60</xref>]
    </td>
    <td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Various skin infection due to pathogens (
     <italic>C. albicans</italic> ATCC 10231, and dermatophyte 
     <italic>T. rubrum</italic> SNB-TR)
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Coridothymus capitatus</italic> L.,
    </td>
    <td rowspan="10" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EOs composition analysis by GC/MS.</p>
      </list-item>
      <list-item>
       <p>Antimicrobial activity was measured using a broth microdilution method.</p>
      </list-item>
     </list>
    </td>
    <td rowspan="10" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO with high amounts of thymol and carvacrol possessed the strongest antimicrobial activity.</p>
      </list-item>
      <list-item>
       <p>These two compounds demonstrated interesting antifungal efficacy against the filamentous fungus 
        <italic>T. rubrum</italic>.
       </p>
      </list-item>
     </list>
    </td>
    <td rowspan="10" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>This study highlights the in vitro antimicrobial activity of some Lebanese Lamiaceae EOs against human pathogens. The antimicrobial potential originates from their high content of either thymol or carvacrol. The results confirmed that some of the Lamiaceae species used in Lebanon ethnopharmacological practices as antimicrobial agents possess antibacterial and antifungal potential.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Lavandula stoechas</italic> L.,
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Lavandula angustifolia</italic> Mill.,
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Mentha spicata</italic> L. subsp. condensata,
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Origanum syriacum</italic> L.,
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Rosmarinus officinalis</italic>,
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Salvia fruticosa</italic> Miller.,
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Satureja cuneifolia</italic> Ten.,
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" rowspan="1" colspan="1">
     <italic>Satureja thymbra</italic> L.,
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Thymbra spicata</italic> L., and 
     <italic>Vitex agnus-castus</italic> L.
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B61-molecules-26-01093" ref-type="bibr">61</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin disease due to six fungal strains (
     <italic>C. tropicalis, C. albicans, Rhizomucor miehei, C. glabrata, A. niger</italic> and 
     <italic>A. fumigates</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Myristica fragrans</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Volatile oil from the leaves was isolated and characterized by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Oil extracts were subjected to antimicrobial assay followed by the Kirby Bauer method.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The most abundant constituents identified were β-pinene, α-pinene and α-thujene.</p>
      </list-item>
      <list-item>
       <p>The oil showed significant inhibitory activity against the fungus 
        <italic>C. tropicalis</italic> (1.3 cm), 
        <italic>C. albicans</italic> (0.8 cm), 
        <italic>R. miehei</italic> (0.6 cm) and 
        <italic>C. glabrata</italic> (0.6 cm).
       </p>
      </list-item>
      <list-item>
       <p>No inhibitory activity was detected against 
        <italic>A. niger</italic> and 
        <italic>A. fumigates.</italic>
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The oil showed significant activity against the tested fungi that suggest the potential of 
        <italic>Myristica fragrans</italic> EO against these diseases.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B62-molecules-26-01093" ref-type="bibr">62</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Keratophilic fungi, a type of dermatophytes causing infection to hair, glabrous skin and nails (
     <italic>A. flavus</italic>, 
     <italic>T. mentagrophytes, T. tonsurans, T. verrucosum, Epidermatophyton floccosum</italic> and 
     <italic>Microsporum nanum)</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Four different commercially available 
     <italic>Itra</italic> (Volatile plant oils): 
     <italic>Bella (Lonicera x bella zabel), Kewda (Pandanus odoratissimus), Rajnigandha (Polianthes tuberosa) and Mogra (Jasminum sambac)</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The strains were identified by a morphological study of culture and microscopic analyses of developed colonies.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity of 
        <italic>Itra</italic> was tested against isolated fungi using agar-well diffusion method.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Better antifungal activity than existing antifungal drugs like terbinafine, itraconazole and fluconazole (taken as control).</p>
      </list-item>
      <list-item>
       <p>The maximum effect was shown by Bella against 
        <italic>T. tosurans</italic> with inhibitory zone of 47 mm.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The paper concluded that 
        <italic>Itra</italic> can be used as an antifungal agent against prevalent keratinophilic fungi.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.</td>
    <td rowspan="2" align="center" valign="middle" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B63-molecules-26-01093" ref-type="bibr">63</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Various skin diseases (
     <italic>C. krusei</italic> H9, 
     <italic>C. guillermondii</italic> MAT23, 
     <italic>C. albicans</italic> ATCC 10231, 
     <italic>C. tropicalis</italic> ATCC 13803, 
     <italic>C. parapsilosis</italic> ATCC 90018, 
     <italic>Cryptococcus neoformans</italic> CECT 1078, 
     <italic>T. mentagrophytes</italic> FF7, 
     <italic>Microsporum canis</italic> FF, 
     <italic>T. rubrum</italic> CECT 2794, 
     <italic>M. gypseum</italic> CECT 2908, 
     <italic>A. niger</italic> F01, 
     <italic>A. fumigatus</italic> F05, 
     <italic>A. fumigatus</italic> F07, 
     <italic>A. fumigatus</italic> F17, 
     <italic>A. flavus</italic> F44, 
     <italic>A. niger</italic> ATCC 16404, 
     <italic>A. fumigatus</italic> ATCC 46645
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Four type oils obtained from 
     <italic>Thymus zygis</italic> subsp. 
     <italic>Sylvestris</italic> (collected at four sites)
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Chemical profiling using GC-FID and GC-MS.</p>
      </list-item>
      <list-item>
       <p>A macrodilution broth method was used to determine the MIC and minimum lethal concentrations (MLC) for yeasts and filamentous fungi.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity of four oils (samples 1–4) was evaluated against yeasts, 
        <italic>Aspergillus</italic> and dermatophyte strains.
       </p>
      </list-item>
      <list-item>
       <p>Cell viability by MTT assay.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Four chemotypes were characterized: carvacrol, thymol, geranyl acetate/geraniol and linalool.</p>
      </list-item>
      <list-item>
       <p>The results demonstrated that the oil with high amounts of carvacrol, which have stronger antifungal activity against dermatophyte strains, showed no cytotoxic effect, at concentrations ranging from 0.08 to 0.16 μL/mL, for as long as 24 h.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The potent antifungal activity of 
        <italic>T. zygis</italic> subsp. 
        <italic>sylvestris</italic> oil against dermatophyte strains was demonstrated, which justifies the widespread use of this plant in traditional medicine. However, further investigation is needed to evaluate the suitability of its antifungal properties in practical applications, namely, in fungal diseases involving mucosal and cutaneous infections, and also as an alternative to synthetic fungicides.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B64-molecules-26-01093" ref-type="bibr">64</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dermatophytosis or ring worm infections (
     <italic>T. rubrum</italic> PTCC 5143, 
     <italic>T. mentagrophytes</italic> PTCC 5054, 
     <italic>M. canis</italic> PTCC 5069, 
     <italic>M. gypseum</italic> PTCC 5070, 
     <italic>T. schoenleinii</italic> PTCC 5221, 
     <italic>T verrucosum</italic> var. 
     <italic>album</italic> PTCC 5056)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Satureja khuzistanica</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Chemical profiling using GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activities of extracts and EO were screened by disc diffusion method, microbroth dilution assay and food poisoning method.</p>
      </list-item>
      <list-item>
       <p>MIC and MFC of extracts and EO were determined by broth microdilution assay.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Carvacrol (94.5%) was the main component of 
        <italic>S. khuzistanica</italic> EO.
       </p>
      </list-item>
      <list-item>
       <p>The antifungal activity of 
        <italic>S. khuzistanica</italic> EO (MIC: 40–190 µg/mL) was higher than its ethanol extract (MIC: 40–770 µg/mL); while 
        <italic>S. khuzistanica</italic> aqueous extract had no antifungal activity against dermatophytes (MIC = 1550–3100 µg/mL).
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The oil can be used as a topical treatment for the control or treatment of skin fungal infections. 
        <italic>S. khuzistanica</italic> EO or its ethanol extract can be further extended to more deeply explore their antifungal activities.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.</td>
    <td align="center" valign="middle" rowspan="1" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B65-molecules-26-01093" ref-type="bibr">65</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Management of dermatophytosis (
     <italic>Candida krusei</italic> H9, 
     <italic>C. guillermondii</italic> MAT 23, 
     <italic>C. albicans</italic> ATCC 10231, 
     <italic>C. tropicalis</italic> ATCC 13803, 
     <italic>C. parapsilosis</italic> ATCC 90018, 
     <italic>C. neoformans</italic> CECT 1078; 
     <italic>T. mentagrophytes</italic> FF7, 
     <italic>M. canis</italic> FF, 
     <italic>E.</italic> FF9, 
     <italic>T. rubrum</italic> CECT 2794, 
     <italic>M. gypseum</italic> CECT 2908, 
     <italic>A. flavus</italic> F44, 
     <italic>A. niger</italic> ATCC 16404, 
     <italic>A. fumigatus</italic> ATCC 46645
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>D. carota</italic> subsp. 
     <italic>gummifer</italic> (Syme) Hook.f.
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Chemical profiling (GC-MS).</p>
      </list-item>
      <list-item>
       <p>MICs and MLCs for yeasts and filamentous fungi were determined using macrodilution broth assays.</p>
      </list-item>
      <list-item>
       <p>Anti-inflammatory and nitric oxide scavenging activity.</p>
      </list-item>
      <list-item>
       <p>Toxicity was investigated using MTT assay in several mammalian cell lines: macrophages (Raw 264.7), keratinocytes (HaCat), hepatocytes (HepG2) and microglia (N9).</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The oil was characterized by high contents of monoterpenes (83.9%), the major compounds being geranyl acetate (37.0%) and α-pinene (30.9%). The daucane sesquiterpene, carotol, was also found in relatively high amounts (11.0%).</p>
      </list-item>
      <list-item>
       <p>The oil was particularly active against dermatophytes and 
        <italic>C. neoformans</italic>, with MIC values ranging from 0.32 to 0.64 μL/mL.
       </p>
      </list-item>
      <list-item>
       <p>The oil demonstrated a strong anti-inflammatory activity by inhibiting nitric oxide (NO) production in both lipopolysaccharide (LPS)-triggered macrophages and microglia cells.</p>
      </list-item>
      <list-item>
       <p>triggered macrophages and microglia cells.</p>
      </list-item>
      <list-item>
       <p>We detected a cytotoxic effect only for the highest concentrations of the oil, thus ensuring a safe toxicological profile at bioactive concentrations.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>These results suggest that 
        <italic>D. carota</italic> subsp. 
        <italic>gummifer</italic> EO should be explored as a natural source of antifungal and anti-inflammatory drugs with potential application both at the peripheral and central nervous system levels, thus supporting in vivo studies focused in the management of dermatophytosis and/or inflammatory-related diseases.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B66-molecules-26-01093" ref-type="bibr">66</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Various skin diseases 
     <break/>
     <italic>(C. albicans</italic> ATCC 10231, 
     <italic>C. parapsilosis</italic> ATCC 90018, 
     <italic>C. tropicalis</italic> ATCC 13803, 
     <italic>C. neoformans</italic> CECT 1078, 
     <italic>C. guillermondii</italic> MAT2, 
     <italic>C. krusei</italic> H9, 
     <italic>A. niger</italic> ATCC 16404, 
     <italic>A. fumigatus</italic> ATCC 46645, 
     <italic>A. flavus</italic> F44, 
     <italic>E. floccosum</italic> FF9
     <italic>, T. mentagrophytes</italic> FF7, 
     <italic>M. canis</italic> FF1, 
     <italic>T. rubrum</italic> CECT 2794, 
     <italic>M. gypseum</italic> CECT 2908, 
     <italic>T. mentagrophytes</italic> var. 
     <italic>interdigitale</italic> CECT 2958, and 
     <italic>T. verrucosum</italic> CECT 2992)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Salvia officinalis</italic> L.
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Chemical profiling by GC and GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity was evaluated against yeasts, dermatophyte and 
        <italic>Aspergillus</italic> strains by broth macrodilution methods.
       </p>
      </list-item>
      <list-item>
       <p>Cell viability by MTT assay.</p>
      </list-item>
      <list-item>
       <p>Anti-inflammatory potential was evaluated by measuring NO production using LPS-stimulated mouse macrophages.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The main compounds of 
        <italic>S. officinalis</italic> oils were 1,8-cineole and camphor.
       </p>
      </list-item>
      <list-item>
       <p>The dermatophyte strains showed more sensitivity to these oils when compared with 
        <italic>Candida</italic> and 
        <italic>Aspergillus</italic> strains, particularly for 
        <italic>T. rubrum</italic> and 
        <italic>E. floccosum</italic> with MIC of 0.64 μL/mL.
       </p>
      </list-item>
      <list-item>
       <p>Among the tested yeasts, 
        <italic>Cryptococcus neoformans</italic> showed more sensitivity with MIC of 0.64 μL/mL.
       </p>
      </list-item>
      <list-item>
       <p>The oils revealed antifungal activity against dermatophyte strains and significantly inhibited NO production stimulated by LPS in macrophages, without affecting cell viability, in concentrations up to 0.64 μL/mL.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>This is the first report addressing the in vitro anti-inflammatory potential of 
        <italic>S. officinalis</italic> oil. These findings demonstrated that bioactive concentrations of 
        <italic>S. officinalis</italic> oils do not affect mammalian macrophages or keratinocytes viability, making them suitable for use in skin care formulations for cosmetic and pharmaceutical purposes.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B67-molecules-26-01093" ref-type="bibr">67</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Various skin diseases (
     <italic>C. albicans ATCC 10231, T. rubrum SNB-TR1, T. mentagrophytes SNBTM1, T. soudanense SNB-TS1, T. violaceum SNB-TV1</italic> and 
     <italic>T. tonsurans SNB-TT1)</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Abies cilicica, Cupressus sempervirens, Juniperus excelsa, Juniperus oxycedrus, Cedrus libani</italic> and 
     <italic>Cupressus macrocarpa</italic> gold crest
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Chemical profiling by GC and GC-MS.</p>
      </list-item>
      <list-item>
       <p>The MICs of these EOs were determined using the broth microdilution technique.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The EOs showed the most interesting bioactivity on the dermatophytes species (MIC values 32–64 µg/mL).</p>
      </list-item>
      <list-item>
       <p>Each of the major compounds of 
        <italic>C. macrocarpa</italic>, as well as artificially reconstructed EOs, were tested on 
        <italic>T. rubrum</italic>, showing a contribution of the minor components to the overall activity. The main components were α-pinene and sabinene.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Lebanese conifer EOs showed interesting antimicrobial activity, particularly against 
        <italic>Trichophyton</italic> species. These EOs should therefore be considered for a possible integration in antimicrobial preparations intended to be used in the treatment of superficial infections.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B68-molecules-26-01093" ref-type="bibr">68</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contact dermatitis and skin infections 
     <break/>(
     <italic>C. krusei</italic> H9, 
     <italic>C. guillermondii</italic> MAT23, 
     <italic>C. albicans</italic> ATCC 10231, 
     <italic>C. tropicalis</italic> ATCC 13803, 
     <italic>C. parapsilosis</italic> ATCC 90018, 
     <italic>C. neoformans</italic> CECT 1078, 
     <italic>E. floccosum</italic> FF9, 
     <italic>T. mentagrophytes</italic> FF7, 
     <italic>M. canis</italic> FF1, 
     <italic>T. rubrum</italic> CECT 2794, 
     <italic>Microsporum gypseum</italic> CECT 2908, 
     <italic>A. flavus</italic> F44, 
     <italic>A. niger</italic> ATCC 16404, 
     <italic>A. fumigatus</italic> ATCC 46645)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Distichoselinum tenuifolium</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Chemical profiling by GC and GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity MIC and MLC were evaluated against yeasts, dermatophyte and 
        <italic>Aspergillus</italic> strains.
       </p>
      </list-item>
      <list-item>
       <p>Cell viability by MTT assay.</p>
      </list-item>
      <list-item>
       <p>Anti-inflammatory potential was evaluated by measuring NO production induced by LPS, in the absence or in the presence of the oil, in a mouse macrophage cell line.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The oils are predominantly composed of monoterpene hydrocarbons, with myrcene being the main compound (47.7–84.6%).</p>
      </list-item>
      <list-item>
       <p>The oils revealed significant antifungal activity against 
        <italic>C. neoformans</italic> and dermatophyte strains, and significantly inhibited NO production stimulated by LPS in macrophages without affecting cell viability at concentrations ranging from 0.64 L/mL to 1.25 L/mL.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>These findings add significant information to the pharmacological activity of 
        <italic>D. tenuifolium</italic> EO, specifically, to its antifungal and anti-inflammatory properties, thus justifying and reinforcing the use of this plant in traditional medicine, mainly for the treatment of contact dermatitis, characterized by a strong inflammatory component, and skin infections. Therefore, their beneficial effects and use in disease prevention, especially when related to fungal infections and inflammation, should be explored in more depth.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B69-molecules-26-01093" ref-type="bibr">69</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections (
     <italic>T. rubrum</italic> and 
     <italic>T. mentagrophytes</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Agathosma betulina</italic> and 
     <italic>Coleonema album</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EOs analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal capacity was evaluated by volatile release plate method.</p>
      </list-item>
      <list-item>
       <p>The mode of action of the EOs volatiles was elucidated using SEM.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The major components of the EO of 
        <italic>A. betulina</italic> were limonene (29.8%), menthone (21.6%), and isomenthone (14.7%), while of 
        <italic>C. album</italic> were pinene (27.4%), and myrcene (14.5%).
       </p>
      </list-item>
      <list-item>
       <p>There was inhibition/reduction of fungal growth in all plates exposed to EO volatiles. However, the rates of inhibition varied among the fungal species, EO and different volumes tested.</p>
      </list-item>
      <list-item>
       <p>The volatiles from 
        <italic>A. betulina</italic> EO showed a remarkable inhibitory effect, with the highest inhibition recorded at 40 µL. The best inhibition was recorded in 
        <italic>T. rubrum</italic> exposed to volatiles at 40 µL of 
        <italic>A. betulina</italic> EO with a fungal growth index of 2.3%, indicating its strong fungicidal effects. 
        <italic>A. betulina</italic> EO (40 µL) resulted in the destruction of hyphae and spores of 
        <italic>T. rubrum</italic>.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The EO volatiles of 
        <italic>A. betulina</italic> had good inhibitory effects on the mycelia growth of 
        <italic>T. rubrum</italic> and 
        <italic>T. mentagrophytes</italic>. The fungicidal effect of EO volatiles on 
        <italic>T. rubrum</italic> was particularly noteworthy. The mode of action of 
        <italic>A. betulina</italic> EO volatiles on the growth of 
        <italic>T. rubrum</italic> mycelia was shown to be through the inhibition of spore growth and production and alteration of the morphology by destruction of the hyphae and spores. EO induced different actions on the mycelia at different concentrations. Limonene and menthone, as the major components of 
        <italic>A. betulina</italic> EO, are probably responsible for this activity, as they have been previously shown to possess antifungal activity. The remarkable activity recorded in this study gives an insight into the potential of 
        <italic>A. betulina</italic> EO as a skin antifungal.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B70-molecules-26-01093" ref-type="bibr">70</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections (
     <italic>T. rubrum</italic> and 
     <italic>T. mentagrophytes</italic>) 
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>C. album</italic> and 
     <italic>C. pulchellum</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EOs analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal capacity of EOs was evaluated by volatile release plate method.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Terpenes formed the major components of the EOs.</p>
      </list-item>
      <list-item>
       <p>Caryophyllene (24.91%), 
        <italic>trans</italic>-β-ocimene (9.49%), β-myrcene (7.96%) and octahydro-7-methyl-3-methylene-4-(1-methylethyl)-β-copaene (7.53%) are the major components of 
        <italic>C. album</italic> EO while bicyclo[3.1.0]hex-2-ene,4-methyl-1-(1-methyethyl)-β-phellandrene (32.04%), (+)-3-carene (10.88%), β-ocimene (9.46%), γ-elemene (8.95%) and α-pinene (7.43%) are the major components of 
        <italic>C. pulchellum</italic> EO.
       </p>
      </list-item>
      <list-item>
       <p>The EO from both plants inhibited the growth of 
        <italic>T. rubrum</italic> in vitro with final mycelia diameter of 0.3 cm and fungal growth index (FGI) of 0%.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>This study revealed the therapeutic value of 
        <italic>C. pulchellum</italic>. 
        <italic>Coleonema album</italic> and 
        <italic>C. pulchellum</italic> should be considered as potential plants for use in skin ointment. However, toxicity studies of 
        <italic>C. pulchellum</italic> EO need to be carried out in order to ensure their safety for topical application.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B71-molecules-26-01093" ref-type="bibr">71</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections (
     <italic>Fusarium sporotrichioides</italic>, 
     <italic>F. moniliforme, T.n mentagrophytes, A. niger</italic>, and 
     <italic>Rhizoctonia lilacina</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Bursera morelensis</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>GC-MS demonstrated the presence of 28 compounds.</p>
      </list-item>
      <list-item>
       <p>The five principal compounds were α-Fellandrene (32.69%), β-Fellandrene (14.79%), o-Cymene (8.71%), Isocaryophyllene (7.48%) and α-Pinene (5.82%).</p>
      </list-item>
      <list-item>
       <p>The EO inhibited all the filamentous fungi except 
        <italic>F. sporotrichioides</italic>. 
        <italic>F. monilifome</italic> (IC50 = 2.27 mg/mL) was the most sensitive fungal strain.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>This work provided evidence of the antimicrobial activity of the 
        <italic>B. morelensis</italic> EO, providing further scientific support for the traditional use of this species.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B72-molecules-26-01093" ref-type="bibr">72</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections
     <break/>(
     <italic>C. albicans, Candida stellatoidea</italic> and 
     <italic>Candida torulopsis</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Physalis angulata</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Antifungal activity by agar well diffusion method.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>C. torulopsis, C. stellatoidea</italic> and 
        <italic>C. albicans</italic> were susceptible to the EO from the aerial and root part of the plant (MIC: 3.75–4.0 mg/mL).
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The observed inhibition of selected fungi by oils of 
        <italic>P. angulata</italic> makes it a promising antimicrobial agent.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B73-molecules-26-01093" ref-type="bibr">73</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dermatophytes and fungi infections
     <break/>(
     <italic>Microsporum gypseum, M. canis, Arthroderma cajetani, T. mentagrophytes, T. tonsurans, E. floccosum, Botrytis cinerea, Pythium ultimum</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Marrubium vulgare</italic> L.
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO analysis by GC/MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity by transplanting mycelium disks from a single culture in stationary phase.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO was high in eugenol (15.29%).</p>
      </list-item>
      <list-item>
       <p>The antifungal activity of different extracts, marrubiin and EO at two concentrations (20 and 100 μg/mL) showed about 50% inhibition for 
        <italic>T. mentagrophytes</italic> and 
        <italic>E. floccosum</italic> for marrubiin at 100 μg/mL.
       </p>
      </list-item>
      <list-item>
       <p>The antiphytopathogenic activity was also evaluated; only marrubiin had activity against 
        <italic>B. cinerea</italic> at the highest dose (32.40%).
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>M. vulgare</italic> and marrubiin can be used as natural antioxidants and antifungal agents for the treatment of skin dermatophyte infections. Complementary investigations should be conducted to assess the effectiveness of this compound.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B74-molecules-26-01093" ref-type="bibr">74</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections 
     <break/>(
     <italic>C.a albicans 1, C. albicans 2, T. rubrum 1, T. rubrum 2, T. violaceum</italic>, and 
     <italic>T. soudanensis</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Eugenia caryophylla</italic> and 
     <italic>Mentha sp cf piperita</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EOs analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity by broth microdilution method M27-A3 and M38-A.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>E. caryophylla</italic> was mainly composed of eugenol (80.0%), square-caryophyllene (8.3%), and eugenol acetate (6.7%) while 
        <italic>M. sp cf piperita</italic> was characterized by piperitone (67.5%), menthol (10.0%) and beta-phellandrene (5.8%).
       </p>
      </list-item>
      <list-item>
       <p>
        <italic>E. caryophylla</italic> EO exhibited the highest antifungal activity with MIC and MFC of 0.25 μL/mL and 0.125 μL/mL for filamentous fungi and MIC of 0.5 μL/mL for both yeast strains while MFC value was 1 μL/mL for one yeast strain and not determined for the second.
       </p>
      </list-item>
      <list-item>
       <p>MFC of 
        <italic>M. sp cf piperita</italic> EO showed weak activity with a MIC of 2.5 μL/mL on 
        <italic>Tricophyton</italic> strains, while no activity was exhibited on 
        <italic>C. albicans</italic> strains.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The results of this work can be used to confirm their traditional uses and can also be proposed as natural ingredients to some industries to treat superficial infections.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B75-molecules-26-01093" ref-type="bibr">75</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin diseases
     <break/>(
     <italic>E. floccosum, M. canis, M. gypseum, T. mentagrophytes, T. mentagrophytes var. interdigitale, T. rubrum, T. verrucosum</italic>, 
     <italic>C. albicans</italic>, C. 
     <italic>guilliermondii, C. krusei, C. parapsilosis, C. tropicalis, C. neoformans, A. flavus, A. fumigatus, A. niger</italic>). 
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Juniperus communis</italic> subsp. 
     <italic>alpina</italic> (Suter) Celak
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity by broth macrodilution method.</p>
      </list-item>
      <list-item>
       <p>Cytotoxicity was tested in a human keratinocyte cell line (HaCaT) through MTT assay.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>J. communis</italic> subsp. 
        <italic>alpina</italic> needles EO was predominantly composed of monoterpene hydrocarbons (78.4%), with the main compounds being sabinene (26.2%), α-pinene (129%) and limonene (10.4%).
       </p>
      </list-item>
      <list-item>
       <p>Antifungal activity demonstrated the potential of needle oil against dermatophytes, particularly for 
        <italic>M. canis</italic> and 
        <italic>T. rubrum</italic>, with MIC and MLC of 0.32 μL/mL.
       </p>
      </list-item>
      <list-item>
       <p>Evaluation of cell viability showed no significant cytotoxicity in HaCaT keratinocytes at concentrations between 0.32 and 0.64 μL/mL.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>These results show that it is possible to find appropriate doses of 
        <italic>J. communis</italic> subsp. 
        <italic>alpina</italic> oil with both antifungal activity and a very low detrimental effect on keratinocytes.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B76-molecules-26-01093" ref-type="bibr">76</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infection sporotrichosis (
     <italic>Sporothrix schenckii fungus</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Turmeric (
     <italic>Curcuma longa</italic>)
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity by disc diffusion method.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>GC MS analysis revealed the presence of more than 20 component, including Ar-turmerone and dehydro Ar-turmerone.</p>
      </list-item>
      <list-item>
       <p>Activity against 
        <italic>S. schenckii</italic> fungus showed zone of growth inhibition was 9 mm by the sample oil after 8 days and 11 mm after 10 days.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>No conclusion was presented.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B77-molecules-26-01093" ref-type="bibr">77</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections (
     <italic>T. rubrum</italic> and 
     <italic>T. mentagrophytes)</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Lavandula luisieri</italic> and 
     <italic>Cymbopogon citratus</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EOs analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity.</p>
      </list-item>
      <list-item>
       <p>Inhibition of conidial germination and antifungal drug/EOs combination assay.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EOs were characterized by a high amount of oxygenated monoterpenes in their composition.</p>
      </list-item>
      <list-item>
       <p>Strong antifungal activity was observed for the majority of clinical strains, and fungicidal activity was demonstrated.</p>
      </list-item>
      <list-item>
       <p>Positive interaction between 
        <italic>L. luisieri</italic> EO combined with terbinafine was observed against terbinafine-resistant strain (Tr ATCC MYA-4438). Significant reduction of the germination was observed above 100 μg/mL.
       </p>
      </list-item>
      <list-item>
       <p>Both oils were safe to macrophage mammalian cells at tested concentration.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>This study describes the antifungal activity of 
        <italic>L. luisieri</italic> and 
        <italic>C. citratus</italic> EOs against dermatophytes, which could be useful in the design of new formulations for topical treatments. This study also proposes 
        <italic>L. luisieri</italic> as a suitable oil for combined treatment against terbinafine-resistant fungal strains, although further in vivo experiments are needed to evaluate the therapeutic efficacy and safety of the EOs in combination with antifungal drugs.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B78-molecules-26-01093" ref-type="bibr">78</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin diseases (
     <italic>Propionibacterium acnes</italic>, 
     <italic>Malassezia</italic> spp., 
     <italic>C. albicans</italic> and 
     <italic>Trichophyton</italic> spp.)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nine EOs
     <break/>(
     <italic>Cyperus scariosus</italic> R. Br., 
     <italic>Syzgium aromaticum</italic> L. Merr et L.M. Perry
     <italic>, Carum carvi</italic> L., 
     <italic>Coriandrum sativum</italic> L.
     <italic>, Boswellia serrata</italic> Roxb. Ex Colebr., 
     <italic>Syzgium cumini</italic> L. Skeels, 
     <italic>Elettaria cardamom</italic> L. Maton, 
     <italic>Occimum sanctum</italic> L. and 
     <italic>Piper nigrum</italic> L.)
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EOs analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity by MIC (microbroth dilution) and zone of inhibition (ZOI) test.</p>
      </list-item>
      <list-item>
       <p>Synergistic activity by Etest and ZOI.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>B. serrata</italic> EO indicates a major composition of α-thujene, ρ-cymene and sabinene.
       </p>
      </list-item>
      <list-item>
       <p>
        <italic>B. serrata</italic> EO demonstrated superior antimicrobial activity against all the micro-organisms, and surprisingly, it showed maximum activity against 
        <italic>Trichophyton</italic> spp.
       </p>
      </list-item>
      <list-item>
       <p>Additionally, 
        <italic>B. serrata</italic> EO combination with azoles showed synergistic activity against azole-resistant strain of 
        <italic>C. albicans</italic>.
       </p>
      </list-item>
      <list-item>
       <p>These broad-spectrum antimicrobial activities of 
        <italic>B. serrata</italic> EO will make it an ideal candidate for topical use.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>B. serrata</italic> EO is a plausible therapeutic agent for the management of skin, scalp and nail infections. Further studies are needed to determine the mode of action and its safety for clinical use, and an analysis should be undertaken of its individual constituents.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B79-molecules-26-01093" ref-type="bibr">79</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections by yeast 
     <break/>(
     <italic>C. albicans</italic> 31, 
     <italic>C. tropicalis</italic> 32, 
     <italic>C. glabrata</italic> 33, 
     <italic>C. glabrata</italic> 35 
     <italic>and C. glabrata</italic> 38)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Six commercial lemon EOs (ETJA, Vera-Nord, Avicenna-Oil, Dufti by Gies, Art, and Croce Azzurra</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EOs analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity by MIC.</p>
      </list-item>
      <list-item>
       <p>GC-MS analysis.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Various lemon EOs had different chemical compositions, but mostly, they contained almost exclusively terpenes and oxygenated terpenes.</p>
      </list-item>
      <list-item>
       <p>The tests show that the antifungal potential of lemon EOs against 
        <italic>Candida</italic> yeast strains is related to the high content of monoterpenoids and the type of strains.
       </p>
      </list-item>
      <list-item>
       <p>From six tested commercial oils, only four (ETJA, Vera-Nord, Avicenna-Oil and Aromatic Art) showed antifungal potential against three 
        <italic>Candida</italic> species (
        <italic>C. albicans, C. tropicalis</italic> and 
        <italic>C. glabrata</italic>).
       </p>
      </list-item>
      <list-item>
       <p>Vera-Nord and Avicenna-Oil showed the best activity, and effectively inhibited the growth of the 
        <italic>C. albicans</italic> strain across the full range of concentrations used.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>This study characterized lemon EOs, which could be used as natural remedies against candidiasis caused by 
        <italic>C. albicans</italic>.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B80-molecules-26-01093" ref-type="bibr">80</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin diseases
     <break/>(
     <italic>M. canis</italic> KCTC 6348, 6349, 6591, 
     <italic>T. rubrum</italic> KCTC 6345, 6352, 6375, 
     <italic>T. mentagrophytes</italic> KCTC 6077 and 6085)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Lonicera japonica</italic> Thunb.
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Antidermatophytic activity of EO by poisoned food technique.</p>
      </list-item>
      <list-item>
       <p>MIC by agar dilution method.</p>
      </list-item>
      <list-item>
       <p>Spore germination and growth kinetics assay.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>L. japonica</italic> EO (1000 ppm) revealed 55.1–70.3% antidermatophytic effect against 
        <italic>Microsporum canis</italic> KCTC 6348, 6349, 6591, 
        <italic>T. rubrum</italic> KCTC 6345, 6352, 6375, 
        <italic>T. mentagrophytes</italic> KCTC 6077 and 6085, respectively, with MIC ranging from 62.5–500 μg/mL.
       </p>
      </list-item>
      <list-item>
       <p>The oil had strong detrimental effect on the spore germination of all the tested dermatophytes, as well as concentration and time-dependent kinetic inhibition of 
        <italic>M. canis</italic> KCTC 6348.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The results demonstrated that 
        <italic>L. japonica</italic> oil could be a potential source of natural fungicides to protect human and animals from fungal infections.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B81-molecules-26-01093" ref-type="bibr">81</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin diseases (
     <italic>Fusarium oxysporum</italic>,
     <break/>
     <italic>T. rubrum</italic> and 
     <italic>T. mentagrophytes</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seventeen EOs</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EOs analysis by GC-MS and GC-FID.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity by M38-A protocol.</p>
      </list-item>
      <list-item>
       <p>Cytotoxicity assay using MTT technique.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Strong activity was demonstrated in 70% to 80% of samples against dermatophytes and from 20% against 
        <italic>F. oxysporum</italic>.
       </p>
      </list-item>
      <list-item>
       <p>The lowest MIC values were obtained with citral chemotype 
        <italic>Lippia alba</italic> oil (BC2) at concentrations of 31.25 and 125 μg/mL on 
        <italic>T. rubrum</italic> and 
        <italic>T. mentagrophytes</italic>, respectively, but not against 
        <italic>F. oxysporum.</italic>
       </p>
      </list-item>
      <list-item>
       <p>Oil from 
        <italic>Minthostachys mollis</italic> (Kunth) Griseb showed strong activity against all fungi evaluated. Active samples against dermatophytes and 
        <italic>F. oxysporum</italic> were not cytotoxic on vero cells ATCC CCL-81; excluding 
        <italic>Lippia origanoides</italic> Kunth (5E), carvone chemotype Lippia alba (TS) and 
        <italic>M. mollis</italic> oil (MEO2) oil.
       </p>
      </list-item>
      <list-item>
       <p>The EOs with the highest selectivity index (SI) values were 
        <italic>Aloysia triphylla</italic> and 
        <italic>L. alba</italic> oil (BC2) on dermatophytes.
       </p>
      </list-item>
      <list-item>
       <p>The main components of most active 
        <italic>L. alba</italic> oils were characterized as carvone (TS, CC1) and citral (BC2). 
        <italic>To L. origanoides</italic> oils, carvacrol (1A, 5E) and thymol (6F) were found as the main components.
       </p>
      </list-item>
      <list-item>
       <p>Pulegone and cis-piperitone epoxide were the main constituents of 
        <italic>M. mollis</italic> MEO1 and MEO2 oils, respectively
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The main components in these EOs may be responsible for their antifungal activity. This finding is very important, because it confirms the potential of these EOs as a source of new antidermatophytes.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B82-molecules-26-01093" ref-type="bibr">82</xref>] 
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Pityriasis versicolor</italic> (
     <italic>Malassezia furfur</italic>) 
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Citrus lemon</italic> (lemon) and 
     <italic>Citrus sinensis</italic> (orange)
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Antifungal activity by disc diffusion and microdilution methods.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>In screening lemon and orange oil by disc diffusion method, the diameter of inhibition zone was found to be 50 and 20 mm, i.e., greater than that of reference antibiotics, that is, gentamycin and streptomycin, which showed 16.5 and 17 mm, respectively.</p>
      </list-item>
      <list-item>
       <p>MIC of lemon and orange oil against 
        <italic>M. furfur</italic> was found to be 0.8 and 2.2 µL/mL.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The findings in this study support the use of lemon and orange oil as a traditional herbal medicine for the control of 
        <italic>P. versicolor</italic> infection in the skin.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B83-molecules-26-01093" ref-type="bibr">83</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections (
     <italic>C. albicans, C. dubliniensis, C. glabrata, C. guilliermondii, C. parapsilosis, C. tropicalis, C. neoformans, Sacharomyces cerevisiae, A. fumigatus,</italic>
     <break/>
     <italic>A. flavus, A. niger</italic>, 
     <italic>T. rubrum, M. canis, Fonsecaea pedrosoi, Pseudallescheria boydii, Fusarium solani, S. schenckii</italic>) 
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Tropaeolum pentaphyllum</italic> Lam. 
     <italic>tubers</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity by MIC.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>GC-MS analysis revealed that the major EO constituent is benzyl isothiocyanate.</p>
      </list-item>
      <list-item>
       <p>The strongest effects against 
        <italic>Candida</italic> spp. and dermatophytes were observed for the EO, with MIC well below 200 µg/mL.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Overall, the results support the use of the plant for the treatment of skin infections, and reveal the main active compounds.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B84-molecules-26-01093" ref-type="bibr">84</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections (
     <italic>T. rubrum</italic> and 
     <italic>C. albicans</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Twenty-nine oils</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Antifungal activity by agar-well diffusion and MIC method.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Most of the EOs showed relatively high antimicrobial activity against all the tested organisms.</p>
      </list-item>
      <list-item>
       <p>The maximum antimicrobial activity was shown by 
        <italic>Calotropis gigantea</italic>, followed by 
        <italic>Semecarpus anacardium, Azadirachta indica, Datura stromium, Coriandrum sativum, Luffa acutangula, Momordica cymbalaria, Gliricidia sepium, Hyptis sauveolens</italic> and 
        <italic>O. sanctum</italic> against the tested fungi.
       </p>
      </list-item>
      <list-item>
       <p>
        <italic>C. gigantae</italic> showed good antimicrobial activity against tested fungi, with MIC values ranging from 0.62 to 40 mg/mL, determined using inhibitory zone estimation.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The obtained results suggest that 
        <italic>C. gigantae</italic> has antimicrobial activity. These results support the hypothesis that the plant oil can be used to cure skin diseases, and may have a role as a pharmaceutical compound and as a preservative.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro—Nonconventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B85-molecules-26-01093" ref-type="bibr">85</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections (
     <italic>Candida pseudotropicalis</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Lippia multiflora</italic>
     <break/>(lippia oil)
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Different concentrations of the oil were incorporated into six different ointment bases.</p>
      </list-item>
      <list-item>
       <p>Tween 80 was incorporated at different concentrations into ointments containing 10% 
        <italic>w/w</italic> lippia oil; a concentration at which minimum antimicrobial activity was observed in the ointment bases.
       </p>
      </list-item>
      <list-item>
       <p>The viscosity, spreadability and stability of the formulations were determined.</p>
      </list-item>
      <list-item>
       <p>Antimicrobial activities of lippia oil in the formulations were determined against selected bacteria and fungi using the agar diffusion assay method; 10% 
        <italic>w/w</italic> salicylic acid formulations were used as reference products.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Incorporation of lippia oil into the ointment bases led to reduction in their viscosity with increase in spreadability.</p>
      </list-item>
      <list-item>
       <p>None of the formulations showed antimicrobial activity at lippia oil content ≤ 5% 
        <italic>w/w</italic>.
       </p>
      </list-item>
      <list-item>
       <p>Inclusion of Tween 80 in the formulations significantly increased the antimicrobial activities of the oil (
        <italic>p</italic> &lt; 0.05).
       </p>
      </list-item>
      <list-item>
       <p>The antimicrobial activities of 10% 
        <italic>w/w</italic> lippia oil formulated in absorption bases containing 6% 
        <italic>w/w</italic> Tween 80 were significantly higher (
        <italic>p</italic> &lt; 0.05) than those formulated in hydrophobic bases.
       </p>
      </list-item>
      <list-item>
       <p>Lippia oil ointment formulations showed greater antimicrobial activities than salicylic acid ointments. Two of the lippia oil ointment formulations bled when subjected to centrifugal force.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Ointment formulations of lippia oil (10% 
        <italic>w/w</italic>) in absorption base (hydrous wool fat ointment BP or simple ointment BP) containing 6% 
        <italic>w/w</italic> Tween 80 were found to be stable and very effective at inhibiting the growth of selected pathogens implicated in skin infections.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29.</td>
    <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro—Nonconventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B56-molecules-26-01093" ref-type="bibr">56</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Different skin infecting pathogens (
     <italic>C. albicans, A. niger</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Piper betle</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Agar well disc diffusion method for zone of inhibition and broth dilution method for MIC.</p>
      </list-item>
      <list-item>
       <p>Gels were formulated using different polymers like hydroxy propyl methyl cellulos (HPMC), Carbopol 934, sodium carboxy methyl cellulose (sodium CMC), and sodium alginate.</p>
      </list-item>
      <list-item>
       <p>Formulation was evaluated for various physico-chemical parameters like pH, viscosity, consistency, homogeneity, spreadability, skin irritation test and stability studies.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>C. albicans</italic> showed maximum sensitivity to the oil that was 24 mm at 20 μL and 20 mm at 20 μL for 
        <italic>A. niger</italic>.
       </p>
      </list-item>
      <list-item>
       <p>Zone of inhibition of oil was not much affected by incorporation into a gel, as confirmed from the antimicrobial results of the final formulations.</p>
      </list-item>
      <list-item>
       <p>DMSO as the cosolvent for EO and carbopol 934 (1%), HPMC (5%) as gelling agent showed the best results in the final formulations.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The gel showed promising antifungal activity against other strains used in this study. The gel was stable at room temperature.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B86-molecules-26-01093" ref-type="bibr">86</xref>] 
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Candidiasis (
     <italic>C. krusei</italic> ATCC 6528, 
     <italic>C. parapsilosis</italic> ATCC 22019, 
     <italic>C. krusei, C. parapsilosis, C. albicans, C. glabrata, C. tropicalis</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Bidens tripartita</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO analysis by GC and GC-MS techniques.</p>
      </list-item>
      <list-item>
       <p>A hydrogel, bigel and oleogel were prepared using an RZR 2020 mechanical stirrer</p>
      </list-item>
      <list-item>
       <p>The antifungal properties of 
        <italic>B. tripartita</italic> EO were also tested against 
        <italic>Candida</italic> species using the modified agar-well diffusion method.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The therapeutic efficacy of the topical formulations is influenced by active phytoconstituents and vehicle characteristics.</p>
      </list-item>
      <list-item>
       <p>The highest activity was observed against 
        <italic>C. tropicalis</italic> and 
        <italic>C. krusei</italic> (3.7 mm difference, compared to hydrogel without BTEO).
       </p>
      </list-item>
      <list-item>
       <p>The main components were 
        <italic>p</italic>-cymen (4.82%), β-linalool (2.85%).
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Among the tested gel formulations combined with BTEO, the hydrogel-based formulation appeared to be the optimal combination, exhibiting antifungal activity against all tested 
        <italic>Candida</italic> strains. This oil appeared to be a promising topical anticandidal agent.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B87-molecules-26-01093" ref-type="bibr">87</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Candidiasis (
     <italic>C. albicans</italic> ATCC 10231, 
     <italic>C. krusei</italic> ATCC 6258 and 
     <italic>C. parapsilosis</italic> ATCC 90098)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mediterranean EOs (
     <italic>Rosmarinus officinalis, Lavandula x intermedia “Sumian</italic>”, 
     <italic>Origanum vulgare</italic> subsp. 
     <italic>hirtum</italic>)
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The antifungal susceptibility test for the selected (clotrimazole- nanostructured lipid carriers) CLZ-NLC formulations was performed based on the broth microdilution method for yeasts, with minor adaptations.</p>
      </list-item>
      <list-item>
       <p>For comparative purposes, in addition to the CLZ-LNLC (
        <italic>Lavandula</italic>) and CLZ-RNLC (
        <italic>Rosmarinus</italic>) formulations, LNLC and RNLC systems were also tested, as well as free EOs (L and R) and free CLZ.
       </p>
      </list-item>
      <list-item>
       <p>The cytotoxicity of all samples (pure EOs and NLC systems) was evaluated through the Alamar Blue
        <sup>®</sup> method.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Results of the in vitro biosafety on HaCaT (normal cell line) and A431 (tumoral cell line) allowed us to select 
        <italic>Lavandula</italic> and 
        <italic>Rosmarinus</italic> as antiproliferative agents with the potential for use as coadjuvants in the treatment of nontumoral proliferative dermal diseases
       </p>
      </list-item>
      <list-item>
       <p>Nanoparticles provided prolonged in vitro release of clotrimazole. In vitro studies against 
        <italic>C. albicans</italic>, 
        <italic>C. krusei</italic> and 
        <italic>C. parapsilosis</italic>, showed an increase of the antifungal activity of clotrimazole-loaded nanoparticles prepared with 
        <italic>Lavandula</italic> or 
        <italic>Rosmarinus</italic>, thus confirming that NLC-containing Mediterranean EOs represent a promising strategy to improve drug effectiveness against topical candidiasis.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Taken together, the results of this study imply that the nanoencapsulation of the selected antifungal drug into NLC systems prepared using Mediterranean EOs as intrinsic oily components is a promising strategy to improve CLZ effectiveness against candidiasis. In particular, the results open the debate concerning the possible application of the properties of 
        <italic>Lavandula</italic> and 
        <italic>Rosmarinus</italic>, whose synergistic effects must be further investigated; this could bring about a strategy for the use of CLZ-EO-NLC to overcome the drug resistance mechanisms associated with the treatment of topical infections.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro—Nonconventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B88-molecules-26-01093" ref-type="bibr">88</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections due to pathogenic fungi(
     <italic>C. albicans, C. tropicalis</italic> and 
     <italic>T. mentagrophytes</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Black pepper, Cardamom, Cumin, Boswellia and Patcholi</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Antifungal activity by agar well diffusion method.</p>
      </list-item>
      <list-item>
       <p>For synergistic activity between Fluconazole and EO, sterile strips of 5 cm × 1 cm were used.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The results indicated that all the oils inhibited fungal strains in varying degrees of dilutions.</p>
      </list-item>
      <list-item>
       <p>Boswellia EO was found to be the most effective in terms of antifungal activity against 
        <italic>C. tropicalis</italic> and Cardamom EO against 
        <italic>T. mentagrophytes</italic>.
       </p>
      </list-item>
      <list-item>
       <p>The results indicated that Boswellia EO and Fluconazole in combination acted as the most powerful antifungal agent against 
        <italic>C. tropicalis</italic>, even at 1:10 dilution and 100 μg/mL, respectively.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>These results indicated that the active components present in EOs should be a focus area of future in vivo research, especially in conjunction with existing antifungal drugs. The molecular mechanisms, mode of action, stability, toxicity, and efficacy of the active components isolated from EOs need to be further studied and evaluated.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and In vivo—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B89-molecules-26-01093" ref-type="bibr">89</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Body aches and dermatitis (
     <italic>A. flavus</italic>, 
     <italic>A. niger</italic>, 
     <italic>F. solani</italic>, 
     <italic>Mucor</italic> piriformis, 
     <italic>Wickerhamomyces anomalus</italic>, 
     <italic>Wickerhamomyces anomalus</italic>, 
     <italic>Deboromyces hansenii,</italic> and 
     <italic>C. albicans</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Parrotiopsis jacquemontiana</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Phytochemical characterization of oil was determined using GC-MS and Fourier Transformed- Infrared spectroscopy (FT-IR).</p>
      </list-item>
      <list-item>
       <p>The antimicrobial potential of oil was investigated by disc diffusion method.</p>
      </list-item>
      <list-item>
       <p>Wound healing was performed in vivo with determination of wound contraction rates, histopathology, hemostatic potential and hydroxyproline estimation.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>GC-MS analysis indicated that the oil was constituted mainly of 2, 6-dimethyl-8-oxoocta-2, 6-dienoic acid, methyl ester (18.2%), syringol (17.8%), catechol (12.4%), guaiacol (5.2%), p-cresol (5.4%) and phenol, 2-propyl- (3.7%).</p>
      </list-item>
      <list-item>
       <p>FT-IR analysis revealed several important functional groups in its chemical composition, especially phenolic O-H compound stretching.</p>
      </list-item>
      <list-item>
       <p>The oil strongly inhibited the growth of various fungal isolates with low minimum inhibitory concentrations (64–256) μg/mL.</p>
      </list-item>
      <list-item>
       <p>Remarkable rate for wound closure and epithelization, hemostatic potential and marked increase (
        <italic>p</italic> &lt; 0.05) in hydroxyproline content were observed during wound healing in rat.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The results suggested that oil can be used as a potential source of wound healing therapeutics.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In vitro and In vivo—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B90-molecules-26-01093" ref-type="bibr">90</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections
     <break/>(
     <italic>Chrysosporium tropicum, Trichophyton simii, T. rubrum</italic> and 
     <italic>Chrysosporium indicum</italic>) 
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Trachyspermum ammi</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>EO analysis by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antidermatophytic activity was determined by disc diffusion method and minimum inhibitory concentration.</p>
      </list-item>
      <list-item>
       <p>Acute dermal irritation assay was applied for toxicological studies on albino mice.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Thymol was found to be the major compound (58.88%), followed by p-cymene (24.02%), γ-terpinene (13.77%) and β-pinene (1.90%).</p>
      </list-item>
      <list-item>
       <p>Maximum zone of inhibition was observed against 
        <italic>C. tropicum</italic> (63.83 +/− 0.166 mm) followed by 
        <italic>T. simii</italic> (57 +/− 0.288 mm), 
        <italic>T. rubrum</italic> (51.33 +/− 0.333 mm) and 
        <italic>C. indicum</italic> (45 +/− 0.577 mm).
       </p>
      </list-item>
      <list-item>
       <p>Five fractions were separated under different temperature conditions, labelled as TA(I)-TA(V). Maximum effects were seen in case of TA(IV) and TA(V) fractions.</p>
      </list-item>
      <list-item>
       <p>Excellent results of TA(V) were observed against 
        <italic>M. gypseum</italic> (0.015 +/− 0.002 mu l/mL), followed by 
        <italic>M. canis</italic> (0.017 +/− 0.002 mu l/mL), 
        <italic>T. rubrum</italic> (0.02 +/− 0.000 mu l/mL) and 
        <italic>C. albicans</italic> (0.05 +/− 0.003 mu l/mL).
       </p>
      </list-item>
      <list-item>
       <p>Low concentrations, i.e., up to 3%, did not show any irritation on mice skin. At 5%, three mice showed mild erythema, while at 7% concentration, all five mice exhibited well-defined erythema</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>This study concluded that the EO of 
        <italic>T. ammi</italic> and its fractions have strong antidermatophytic properties with no side effect at low concentrations, and thus, could represent alternatives to antibiotics.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B91-molecules-26-01093" ref-type="bibr">91</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin disease due to fungi strains(
     <italic>C. albicans, C. parapsilosis, C. tropicalis; A. niger, A. terreus, A. flavus, A. fumigatus, Penicillium</italic> sp. and 
     <italic>Mucor</italic> sp.
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lemon grass (
     <italic>Cymbopogon citratus</italic> (DC.) Stapf)
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>LGEO chemical profiling by GC-MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal activity using disc diffusion and vapor diffusion methods.</p>
      </list-item>
      <list-item>
       <p>The anti-inflammatory potential of LGEO was assessed by the carrageenan-induced paw edema test.</p>
      </list-item>
      <list-item>
       <p>Topical anti-inflammatory activity was evaluated as inhibition of croton oil-induced ear edema in mice.</p>
      </list-item>
      <list-item>
       <p>The resulting inflammatory reaction was also evaluated by microscopic inspection.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The major components were geranial (42.2%), neral (31.5%), and β-myrcene (7.5%).</p>
      </list-item>
      <list-item>
       <p>LGEO exhibited promising antifungal effects against 
        <italic>C. albicans, C. tropicalis</italic>, and 
        <italic>A. niger</italic>, with different inhibition zone diameters (IZDs) (35–90 mm). IZD increased with increasing oil volume.
       </p>
      </list-item>
      <list-item>
       <p>Higher anti-
        <italic>Candida</italic> activity was observed in the vapor phase.
       </p>
      </list-item>
      <list-item>
       <p>In an evaluation of the anti-inflammatory effect, LGEO (10 mg/kg, administered orally) was shown to significantly reduce carrageenan-induced paw edema, with a similar effect to that of oral diclofenac (50 mg/kg), which was used as the positive control. Oral administration of LGEO showed dose-dependent anti-inflammatory activity.</p>
      </list-item>
      <list-item>
       <p>In addition, topical application of LGEO in vivo indicated a potent anti-inflammatory effect, as demonstrated by the use of a mouse model of croton oil-induced ear edema. To our knowledge, this is the first such report to be published. The topical application of LGEO at doses of 5 and 10 µL/ear significantly reduced acute ear edema induced by croton oil in 62.5 and 75% of mice, respectively.</p>
      </list-item>
      <list-item>
       <p>In addition, histological analysis clearly confirmed that LGEO inhibits the skin inflammatory response in animal models.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The results of this present study indicated that LGEO has potential in the development of drugs for the treatment of fungal infections and skin inflammation that should be explored in future studies.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and In vivo—Conventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B92-molecules-26-01093" ref-type="bibr">92</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections
     <break/>(
     <italic>M. gypseum</italic> and 
     <italic>T. mentagrophytes</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Ageratum houstonianum</italic> Mill.,
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The proportions of EO/griseofulvin tested were 8:2 and 10:1 (
        <italic>w/w</italic>).
       </p>
      </list-item>
      <list-item>
       <p>The acute dermal toxicity of this oil was evaluated on guinea-pigs (
        <italic>Cavia porcellus</italic>) using a standard method.
       </p>
      </list-item>
      <list-item>
       <p>Agar dilution method with serial dilution of the oil and the mixtures was used for antidermatophytic tests.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The MIC of the EO was 80 μg/mL for the tested dermatophytes.</p>
      </list-item>
      <list-item>
       <p>The 8:2 mixture was 20 μg/mL, whereas those of the 10:1 mixture were 8 and 10 ug mL for 
        <italic>M. gypseum</italic> and 
        <italic>T. mentagrophytes</italic>, respectively.
       </p>
      </list-item>
      <list-item>
       <p>Compared to the control group, we noted no diarrhoea, nor any change in treated skin or fur appearance. In contrast, the degree of sensitivity to noise, reaction to pinch, activity (locomotion) and reactivity decreased with increases in the dose. The LD50 was determined to be 5 g/kg b.wt.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>These data suggest that the EO of the leaves of 
        <italic>A. houstonianum</italic> contains antidermatophytic compounds, and may not be toxic when used topically. A potentialization effect was observed between the EO and griseofulvin.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and In vivo—Nonconventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B93-molecules-26-01093" ref-type="bibr">93</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin disease (
     <italic>C. albicans</italic> strain ATC 100231)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lemongrass oil (LGO) is a volatile oil extracted from the leaves of 
     <italic>C. citratus</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>MIC and MFC of LGO were determined using the broth macrodilution method. LGO-loaded nanosponges were prepared using the emulsion solvent evaporation method.</p>
      </list-item>
      <list-item>
       <p>The irritation effect of the chosen gel formulation, F9, was evaluated by carrying out a Draize patch test on six albino rats. The animals’ backs were shaved 24 h before the application of the formulation, and then 0.5 g gel was spread uniformly on the hair-free skin within an area of 4 cm
        <sup>2</sup>. The skin was observed for any visible changes after 24, 48, and 72 h from the application of the formulation.
       </p>
      </list-item>
      <list-item>
       <p>Male albino rats weighing 150–180 g were housed in individual cages and given access to food and water ad libitum. Animals were subjected to intraperitoneal injection of cyclophosphamide (100 mg/kg, body weight) for three days before fungal infection to suppress their immunity, with the aim of achieving a heavy cutaneous infection.</p>
      </list-item>
      <list-item>
       <p>
        <italic>C. albicans</italic>, ATCC 10231 was used to induce infection.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The minimal inhibitory concentration and minimal fungicidal concentration of LGO against 
        <italic>C. albicans</italic> strain ATC 100231, determined using the broth macrodilution method were found to be 2 and 8 µL/mL, respectively.
       </p>
      </list-item>
      <list-item>
       <p>The selected formulation, F9, was tested for skin irritation and antifungalactivity against 
        <italic>C. albicans</italic>; the results confirmed the nonirritancy and effective antifungal activity of the prepared hydrogel.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>LGO was successfully incorporated into an EC nanosponge using the emulsion solvent evaporation method, followed by integration into a carbopol hydrogel. Among the nine prepared hydrogels integrating lemongrass-loaded nanosponges, the F9 formulation was chosen for further study on the basis of its particle size and controlled release profile. The selected formula showed no skin irritation and in vivo antifungal activity in male albino rats. These results are promising with respect to the practical application of the incorporation of LGO in pharmaceutical formulations with the benefit of decreasing the hazards of its use in folk medicine in crude form.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and In vivo—Nonconventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B94-molecules-26-01093" ref-type="bibr">94</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin infections (
     <italic>T. mentagrophytes, T. rubrum, T. verrucosum</italic> and 
     <italic>M. canis</italic>) 
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Cymbopogon martini</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Hydrodistillation aerial part 
        <italic>C. martini</italic> and topical formulations were prepared in five different semisolid bases.
       </p>
      </list-item>
      <list-item>
       <p>In vitro antimicrobial investigations were performed on EO and topical formulations.</p>
      </list-item>
      <list-item>
       <p>Skin sensitizations of the formulations were evaluated using guinea pig maximization-</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>
        <italic>C. martini</italic> EO has shown broad-spectrum antimicrobial potency against all tested organisms, with MIC value ranging from 0.65 to 10 μg/mL.
       </p>
      </list-item>
      <list-item>
       <p>Absolute inhibitions of growth of fungi were observed against 
        <italic>T. mentagrophytes</italic> and 
        <italic>T. rubrum</italic> at concentrations above 1% of oil and against 
        <italic>M. canis</italic> and 
        <italic>T. verrucosum</italic> at a concentration of 4% oil.
       </p>
      </list-item>
      <list-item>
       <p>Among topical formulations, the highest antimicrobial activity was recorded in hydrophilic ointment, followed by the macrogol blend ointment.</p>
      </list-item>
      <list-item>
       <p>The antimicrobial activity of oil was higher in fungal pathogens compared to bacteria. Gram-positive bacteria were more sensitive than gram-negative bacteria.</p>
      </list-item>
      <list-item>
       <p>A hydrophilic and macrogol blend containing 5% oil did not produce any skin sensitization on guinea pigs.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Topical formulations of 
        <italic>C. martini</italic> EO may be alternative topical agents with safe broad-spectrum activity for the treatment of skin disorders. Further studies should focus on shelf-life and clinical studies of the product.
       </p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and In vivo—Nonconventional technology</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B95-molecules-26-01093" ref-type="bibr">95</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dermatophytes and some filamentous fungi 
     <italic>(A. flavus, A. niger, A. fumigatus, Microspoum audouni, M. nanum, T. mentagrophytes, T. verrucosm</italic> and 
     <italic>T. violaceum</italic>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>C. martini</italic> and 
     <italic>Chenopodium ambrosioides</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Chemical constituents of EOs were determined by GC–MS.</p>
      </list-item>
      <list-item>
       <p>The fungitoxicity of EOs and their combinations was also evaluated against some filamentous fungi and other species of dermatophytes by poisoned food technique at concentrations of 200, 600 and 800 ppm.</p>
      </list-item>
      <list-item>
       <p>Male guinea pigs (5–8 months old, 350–400 g) were obtained from Central Animal House, Institute of Medical Sciences, BHU, Varanasi.</p>
      </list-item>
      <list-item>
       <p>The ointment of each EO and their combination were prepared by mixing 1 mL of the oil with 100 g petroleum jelly.</p>
      </list-item>
      <list-item>
       <p>Treatments were started from the sixth day after inoculation and continued until complete recovery was achieved. To the infected area was applied 0.2 g ointment twice a day in the treatment set. In the control set, only petroleum jelly without EO was used.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The major constituents of the essential oil of 
        <italic>C. martini</italic> were 
        <italic>trans</italic>-geraniol (60.9%), β-elemene (12.26%), 
        <italic>E</italic>-citral (3.95%) and linalool (3.44%).
       </p>
      </list-item>
      <list-item>
       <p>The minimum inhibitory concentrations of EO and of their combination were found between 150 and 500 ppm, while those of known antifungal drugs ranged from 1000 to 5500 ppm.</p>
      </list-item>
      <list-item>
       <p>EOs ointments were prepared and applied against induced ringworm in a guinea pig model. Disease removal was observed in 7–21 days, and the hair samples showed negative results for fungal culture in a time-dependent manner after the application of EO ointments.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The results provided scientific validation for the use of these EOs in the treatment of dermatophyte infections; as such, the topical application of these EOs may be recommended as an alternative to synthetic drugs.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.</td>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Clinical Interventions</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B96-molecules-26-01093" ref-type="bibr">96</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ringworm (
     <italic>tenia corporis</italic>) (
     <italic>M.</italic> and 
     <italic>T. mentagrophytes)</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Curcuma longa</italic> L.
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The oil was formulated in the form of an ointment, 1% w/v and subjected to topical testing on patients of the Out Patient Department (OPD) at Moti Lal Nehru Medical College, Allahabad. Patients were selected on the basis of potassium hydroxide (KOH) positive results and diagnosis of tenia corporis.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>A 
        <italic>C. longa</italic> leaves EO was fungicidal at 2.5 μL/mL, at which it was tolerated in heavy doses. The fungicidal activity was thermostable up to 80 °C and a shelf life of up to 24 months was determined.
       </p>
      </list-item>
      <list-item>
       <p>The oil also showed a broad fungitoxic spectrum, inhibiting the mycelial growth of other fungi, viz., 
        <italic>E. floccosum, M. nanum, T. rubrum, T. violaceum</italic>.
       </p>
      </list-item>
      <list-item>
       <p>Moreover, at up to 5% concentration, it did not exhibit any adverse effect on mammalian skins.</p>
      </list-item>
      <list-item>
       <p>After the second week of treatment, all patients were KOH-negative. At the end of medication, 75% of patients recovered completely, while 15% showed significant improvement from the disease.</p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>After ongoing successful clinical trials, it was concluded that the ointment could be exploited commercially. The relationship of dermatophytes to the toxicity of the oil, vis-a-vis phylogeny, evaluated using the molecular data of the pathogens, was also discussed.</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B97-molecules-26-01093" ref-type="bibr">97</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Pityriasis versicolor</italic> (
     <italic>Malassezia</italic> sp.)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <italic>Myrtus communis</italic>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Forty one patients with PV that had not received any treatment for PV two weeks prior to enrollment.</p>
      </list-item>
      <list-item>
       <p>Samples were taken from four different locations: the surface layers of the back, thorax, arms and facial skin (area of 4 cm
        <sup>2</sup>), using adhesive tape.
       </p>
      </list-item>
      <list-item>
       <p>Chemical profiling via LC–MS/MS.</p>
      </list-item>
      <list-item>
       <p>Antifungal effect of EO on 
        <italic>Malassezia</italic> strains was tested using European committee on antimicrobial susceptibility testing (EUCAST) broth microdilution method.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Study was performed on 22 men (~ 54%) and 19 women (~ 46%) aged 20–80 years (mean 43 ± 16).</p>
      </list-item>
      <list-item>
       <p>A total of 86 yeast colonies were isolated from 41 patients with PV.</p>
      </list-item>
      <list-item>
       <p>Seven different 
        <italic>Malassezia</italic> species were identified as follows: 
        <italic>M. furfur</italic> (42.5%, 37/86), 
        <italic>M. sympodialis</italic> (23.5%, 20/86), 
        <italic>M. slloofae</italic> (13.9%, 12/86), 
        <italic>M. globosa</italic> (7.5%, 7/86), M. obtusa (6%, 5/86), 
        <italic>M. japonica</italic> (4%, 3/86) and 
        <italic>M. restricta</italic> (2.5%, 2/86).
       </p>
      </list-item>
      <list-item>
       <p>The most and least infected sites were back (74.5, 31/41) and forehead (11.8%, 5/41), respectively.</p>
      </list-item>
      <list-item>
       <p>Inhibition of fungal growth with 
        <italic>M. communis</italic> EO was efective in 96% (36/37) of isolated 
        <italic>M. furfur</italic>, 83% (16/20) of 
        <italic>M. sympodialis</italic>, 78% (9/12) of M. sloofae, 78% (5/7) of 
        <italic>M. globosa</italic>, 75% (4/5) 
        <italic>M. obtusa</italic>, 73% (2/3) of 
        <italic>M. japonica</italic> and 62% (1/2) of 
        <italic>M. restricta</italic>.
       </p>
      </list-item>
     </list>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>The broad-spectrum antimicrobial activities of 
        <italic>M. communis</italic> EO and its potent inhibiting activity on 
        <italic>Malassezia</italic> growth deserve further research, with the aim of potentially applying this EO in the topical treatment of skin diseases
       </p>
      </list-item>
     </list>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
